StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Niki BioSolutions operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Niki BioSolutions's operating cash flow for the twelve months ending Dec 31, 2025 was -$1.84M. For fiscal 2025 it was -$1.84M. The highest annual figure on record is -$1.19M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.84M–
FY2024Dec 31, 2024-$1.19M–
FY2023Dec 31, 2023-$7.72M–
FY2022Dec 31, 2022-$12.32M–
FY2021Dec 31, 2021-$14.65M–
FY2020Dec 31, 2020-$15.93M–
FY2019Dec 31, 2019-$13.38M–
FY2018Dec 31, 2018-$10.04M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$535.72K–
Q3 FY2025Sep 30, 2025-$484.28K–
Q4 FY2024Dec 31, 2024$119.65K–
Q3 FY2024Sep 30, 2024-$28.49K–

More Niki BioSolutions figures

See a number that looks wrong?